One in Five Announces Two New Appointments

One in Five is delighted to announce two new appointments as we continue to grow and strengthen our organisation, positioning us for an exciting future.

We are pleased to welcome Lou Wardlaw as our new part-time Chief Executive Officer and Kristine Cooney GAICD as our new Board Chair.

CEO Appointment – Lou Wardlaw

Lou Wardlaw joins One in Five as our new part-time CEO, bringing more than 25 years of senior leadership experience across transformation, customer experience and people leadership, alongside her work as a facilitator, coach and mental health advocate. Having served as Chair of One in Five, she brings a deep understanding of the organisation and a strong personal commitment to its mission. Lou is passionate about growing One in Five’s impact and increasing investment in medical research to improve treatments and ultimately find cures for mental illness.Lou will work closely with the Board, staff and our broader community to build on the organisation’s strong foundations and support One in Five’s continued growth and impact.

Board Chair – Kristine Cooney GAICD

Kristine Cooney is an accomplished executive with more than 30 years’ experience across a variety of sectors, including telecoms, infrastructure and public health. She brings extensive experience in leadership, strategy, organisational development and stakeholder engagement, together with a strong commitment to creating positive social impact. "I believe now is the right time and with the right team to do this and we will continue to ensure every engagement and kindly donated dollar works as hard as possible to achieve our vision of none in five" As Board Chair, Kristine will work closely with Lou and the Board to provide strategic leadership and governance as One in Five enters this next stage of its development.

These appointments represent an important step forward for One in Five, strengthening our leadership and governance as we continue our work to find cures and bring hope for mental illness through funding medical research.